Luther King Capital Management (LKCM)
BSX icon

Luther King Capital Management (LKCM)’s Boston Scientific BSX Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Sell
10,750
-40,481
-79% -$2.2M ﹤0.01% 498
2026
Q1 		$3.21M Sell
51,231
-1,390
-3% -$111K 0.01% 303
2025
Q4 		$5.02M Buy
52,621
+5,770
+12% +$566K 0.02% 258
2025
Q3 		$4.57M Buy
46,851
+36,454
+351% +$3.78M 0.02% 260
2025
Q2 		$1.12M Buy
10,397
+87
+0.8% +$8.8K ﹤0.01% 398
2025
Q1 		$1.04M Buy
10,310
+60
+0.6% +$6.04K ﹤0.01% 405
2024
Q4 		$916K Sell
10,250
-13
-0.1% -$1.14K ﹤0.01% 410
2024
Q3 		$860K Buy
10,263
+73
+0.7% +$5.75K ﹤0.01% 420
2024
Q2 		$785K Hold
10,190
– – ﹤0.01% 426
2024
Q1 		$698K Hold
10,190
– – ﹤0.01% 440
2023
Q4 		$589K Hold
10,190
– – ﹤0.01% 441
2023
Q3 		$538K Sell
10,190
-164
-2% -$8.6K ﹤0.01% 456
2023
Q2 		$560K Buy
10,354
+79
+0.8% +$4.13K ﹤0.01% 464
2023
Q1 		$514K Buy
10,275
+25
+0.2% +$1.18K ﹤0.01% 460
2022
Q4 		$474K Sell
10,250
-149
-1% -$6.45K ﹤0.01% 460
2022
Q3 		$403K Hold
10,399
– – ﹤0.01% 472
2022
Q2 		$388K Sell
10,399
-538
-5% -$21.9K ﹤0.01% 508
2022
Q1 		$484K Buy
10,937
+239
+2% +$10.4K ﹤0.01% 483
2021
Q4 		$454K Sell
10,698
-158
-1% -$6.64K ﹤0.01% 505
2021
Q3 		$471K Buy
10,856
+206
+2% +$9.11K ﹤0.01% 500
2021
Q2 		$455K Sell
10,650
-67
-0.6% -$2.82K ﹤0.01% 513
2021
Q1 		$414K Sell
10,717
-276
-3% -$10.4K ﹤0.01% 478
2020
Q4 		$395K Sell
10,993
-15,539
-59% -$560K ﹤0.01% 474
2020
Q3 		$1.01M Hold
26,532
– – 0.01% 328
2020
Q2 		$932K Sell
26,532
-1,380
-5% -$49.7K 0.01% 328
2020
Q1 		$911K Sell
27,912
-675
-2% -$26.4K 0.01% 314
2019
Q4 		$1.29M Buy
28,587
+281
+1% +$11.8K 0.01% 325
2019
Q3 		$1.15M Buy
28,306
+10,010
+55% +$424K 0.01% 329
2019
Q2 		$786K Sell
18,296
-21,466
-54% -$826K 0.01% 356
2019
Q1 		$1.53M Hold
39,762
– – 0.01% 298
2018
Q4 		$1.41M Buy
39,762
+22
+0.1% +$798 0.01% 293
2018
Q3 		$1.53M Buy
39,740
+15,205
+62% +$531K 0.01% 314
2018
Q2 		$802K Buy
+24,535
New +$740K 0.01% 373

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Luther King Capital Management (LKCM)'s BSX Position: Q2 2026 in Review

Luther King Capital Management (LKCM) reduced its Boston Scientific (BSX) stake by 79% in Q2 2026, selling an estimated $2.2M and leaving 10,750 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Luther King Capital Management (LKCM) first reported a position in BSX in Q2 2018 and has held it in 33 quarters since. The position peaked at $5.02M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Luther King Capital Management (LKCM) held 10,750 shares of Boston Scientific worth $459K as of Q2 2026.
  • Luther King Capital Management (LKCM) sold 40,481 Boston Scientific shares in Q2 2026, an estimated $2.2M.
  • Boston Scientific made up ﹤0.01% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #498 holding.
  • Luther King Capital Management (LKCM) first reported a position in Boston Scientific in Q2 2018 and has held it in 33 quarters since.
  • Luther King Capital Management (LKCM)'s Boston Scientific position peaked at $5.02M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.